Table 3. Factors associated with interventions in the overall population.
| Univariable Analysis | Multivariable Analysis | |||||||
|---|---|---|---|---|---|---|---|---|
| Palliative Chemotherapy vs. Best Supportive Care (OR 95%CI) | p-value | Surgery vs. Best Supportive Care (OR (95%CI) | p-value | Palliative Chemotherapy vs. Best Supportive Care (OR 95%CI) | p-value | Surgery vs. Best Supportive Care (OR 95%CI) | p-value | |
| Age, ≥70 years | 0.39 (0.27–0.56) | < .0001 | 0.63 (0.46–0.87) | 0.004 | 0.35 (0.35–0.75) | 0.0007 | 0.70 (0.48–1.04) | 0.07 |
| Gender, Female | 0.71 (0.51–0.99) | 0.04 | 0.64 (0.47–0.88) | 0.006 | 0.69 (0.48–0.99) | 0.046 | 0.71 (0.49–1.03) | 0.07 |
| Site, Gallbladder | 0.62 (0.44–0.87) | 0.006 | 0.55 (0.40–0.77) | 0.0004 | 0.55 (0.38–0.81) | 0.002 | 0.79 (0.53–1.17) | 0.25 |
| CCI | 0.87 (0.76–0.99) | 0.03 | 1.00 (0.91–1.09) | 0.95 | 0.90 (0.78–1.02) | 0.10 | 1.04 (0.94–1.16) | 0.42 |
| Stage I / Stage II | 0.31 (0.19–0.51) | < .0001 | 5.97 (4.20–8.49) | < .0001 | 0.31 (0.18–0.53) | < .0001 | 6.08 (4.10–9.03) | < .0001 |
| ECOG, ≥2 | 0.30 (0.18–0.51) | < .0001 | 0.09 (0.04–0.19) | < .0001 | 0.37 (0.22–0.65) | 0.0005 | 0.09 (0.04–0.20) | < .0001 |
Abbreviations: ECOG PS: European Cooperative Oncology Group Performance Status; CCI: Charlson Co-morbidity index